New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations [Yahoo! Finance]
OptimizeRx Corporation (OPRX)
NASDAQ:AMEX Investor Relations:
optimizerx.com/investors
Company Research
Source: Yahoo! Finance
• OPRX Closes First Combined HCP and DTC DAAP Marketing Program for Top 5 Pharma Client WALTHAM, Mass., June 20, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, announced today the publication of its latest white paper, Conversations that Convert: Physician Survey on Opportunities for HCP and DTC Marketing Synchronization The white paper reveals findings from a 2024 independent research survey, commissioned by OptimizeRx, on the effects of direct-to-consumer (DTC) pharmaceutical marketing. Over 170 physicians across seven specialties offered their perspectives about how the care journey can be impacted by marketing. Most notably, it highlights the disconnect between medically supported treatment information provided by HCPs and the treatment information received by consumers, primarily due to siloed, poorly
Show less
Read more
Impact Snapshot
Event Time:
OPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPRX alerts
High impacting OptimizeRx Corporation news events
Weekly update
A roundup of the hottest topics
OPRX
News
- OptimizeRx (NASDAQ:OPRX) shareholders have endured a 83% loss from investing in the stock three years ago [Yahoo! Finance]Yahoo! Finance
- OptimizeRx Co. (NASDAQ: OPRX) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $16.00 price target on the stock.MarketBeat
- New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical ConversationsGlobeNewswire
- OptimizeRx Co. (NASDAQ: OPRX) had its price target raised by analysts at JMP Securities from $15.00 to $16.00. They now have a "market outperform" rating on the stock.MarketBeat
- OptimizeRx Co. (NASDAQ: OPRX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $13.00 price target on the stock.MarketBeat
OPRX
Earnings
- 5/14/24 - Beat
OPRX
Sec Filings
- 6/18/24 - Form S-8
- 6/12/24 - Form 4
- 6/11/24 - Form 4
- OPRX's page on the SEC website